[Translational research of novel PAI-1 inhibitors].
dantks@m.tains.tohoku.ac.jp
Takashi
T
Dan
Toshio
T
Miyata
D000818:Animals; D002544:Cerebral Infarction / Q000517:prevention & control; D015195:Drug Design; D006801:Humans; D017202:Myocardial Ischemia / Q000517:prevention & control; D010879:Piperazines; D017395:Plasminogen Activator Inhibitor 1 / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D015842:Serine Proteinase Inhibitors / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D057170:Translational Research, Biomedical; D062366:para-Aminobenzoates
C549556:5-chloro-2-(((2-(4-(diphenylmethyl)piperazin-1-yl)-2-oxoethoxy)acetyl)amino)benzoate; D010879:Piperazines; D017395:Plasminogen Activator Inhibitor 1; D015842:Serine Proteinase Inhibitors; D062366:para-Aminobenzoates